The “Chinese Expert Consensus on Antiplatelet Therapy”, developed and promulgated by the Chinese Society of Cardiovascular Diseases and the Editorial Board of the Chinese Journal of Cardiovascular Diseases, concluded that individuals without significant cardiovascular disease who have a 10-year risk of cardiovascular disease ≥10% with a combination of 3 or more of the following risk factors should take aspirin (75-100 mg/d) for long-term primary prevention: 1. The primary prevention should be long-term aspirin (75-100 mg/d): 1, men ≥ 50 years of age or women after menopause; 2, hypertension; 3, hypercholesterolemia; 4, obesity (body mass index ≥ 28 kg/m2); 5, family history of early-onset cardiovascular disease (men < 55 years of age, women < 65 years of age); 6, diabetes mellitus; 7, smoking. In addition, hypertensive patients with combined chronic ischemic kidney disease are also indications for primary prevention with aspirin.